Bausch Health Companies | VRX - Заемный капитал





Заемный капитал Изменить Дата
Amgen USD 51.89B 1.88B 2026-03
ANI Pharmaceuticals USD 286M 5.84M 2026-03
Aurora Cannabis CAD 18.13M 15.07M 2026-03
Bausch Health Companies USD 19.9B 720M 2026-03
Biogen USD 6.29B 1.7M 2026-03
Bristol-Myers Squibb USD 42.15B 698M 2026-03
Canopy Growth CAD 217.12M 7.87M 2026-03
Danaher USD 25.15B 7.59B 2026-06
Drreddys Laboratories INR 12.2B 12.07B 2026-03
Eli Lilly USD 39.37B 1.5B 2026-03
Gilead Sciences USD 20.86B 1.27B 2026-03
Nektar Therapeutics USD 63.16M 44.35M 2025-12
Novo Nordisk DKK 119.17B 231M 2026-03
Pacira USD 367.66M 4.53M 2026-03
Perrigo USD 3.62B 17.5M 2026-03
Phibro Animal Health USD 597.68M 5.92M 2026-03
Prestige Brands USD 1.01B 40.28M 2026-03
Supernus Pharmaceuticals USD 400.38M 21.13M 2022-03
Vertex Pharmaceuticals USD 106.7M 4.7M 2025-12
Zoetis USD 9.04B 3M 2026-03